Vialwirebiotech, curated
October 1, 2026, 8:50 AM
August 2, 2026
- 3:18 AM · SCMP — Tech3:18 AMCUHK earmarks Pak Shek Kok site for new medical building and 10th college — SCMP — Tech
August 1, 2026
- 10:00 AM · SCMP — Tech10:00 AMPain or gain? US moves to decouple its defence industry from China’s rare earths — SCMP — Tech
July 31, 2026
- 4:47 PM · Bloomberg — Technology4:47 PMIllumina CEO on Genomic Sequencing Opportunities and AI — Bloomberg — Technology
- 12:00 PM · BioWorld12:00 PMWith sleep apnea drug under review, Apnimed prices $192M IPO — BioWorld
- 12:00 PM · BioWorld12:00 PMMimedx to buy Sanara for $350M to move beyond wound care — BioWorld
- 12:00 PM · BioWorld12:00 PMLow coffers, failed endometrial cancer trial: Karyopharm down 72% — BioWorld
- 11:45 AM · BioPharma Dive11:45 AMResilience and Lilly invest $750M to boost Cincinnati drug production — BioPharma Dive
- 10:42 AM · Drug Discovery World10:42 AMTreatment underway for nonobstructive hypertrophic cardiomyopathy — Drug Discovery World
- 9:19 AM · Drug Discovery World9:19 AMGSK teams up with Relation to improve disease biology knowledge — Drug Discovery World
- 9:00 AM · BioWorld9:00 AMUMF-814A sheds light on spliceosome-mutant myeloid disorders — BioWorld
- 9:00 AM · BioWorld9:00 AMTaisho licenses Japanese rights to Kaigene’s KG-006 — BioWorld
- 9:00 AM · BioWorld9:00 AMSunrock Biopharma reports new CCR9-targeting ADCs — BioWorld
- 9:00 AM · BioWorld9:00 AMTahrget Therapeutics discloses new viral DNA polymerase inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMSitala Bio identifies new complement factor B inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMMira advances MIRA-55 and SKNY-1 — BioWorld
- 9:00 AM · BioWorld9:00 AMCreate Medicines’ CRT-402 cleared to enter clinic in Australia — BioWorld
- 9:00 AM · BioWorld9:00 AMTSC Alliance and Apertura Gene Therapy collaboration progresses — BioWorld
- 9:00 AM · BioWorld9:00 AMTuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMApex Bioscience discovers new PDE4 and PDE5 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMLiver-targeted ASO tackles early MASLD — BioWorld
- 9:00 AM · BioWorld9:00 AMOlix’s OLX-501A reduces visceral fat in obese NHPs — BioWorld